What omeprazole dose does the British National Formulary for Children recommend for a child weighing 22.6 kg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Omeprazole Dosing for a 22.6 kg Child

For a child weighing 22.6 kg, the recommended omeprazole dose is 20 mg once daily for symptomatic GERD or erosive esophagitis. 1

Weight-Based Dosing Thresholds

The British National Formulary for Children (BNFC) and American Academy of Pediatrics use weight-based thresholds for omeprazole dosing in children aged 2-16 years:

  • Children weighing 10 to <20 kg: 10 mg once daily 1
  • Children weighing ≥20 kg: 20 mg once daily 1

Since this child weighs 22.6 kg, they fall into the ≥20 kg category and should receive the 20 mg daily dose. 1

Administration Considerations

  • For children unable to swallow capsules: Mix omeprazole pellets with applesauce for easier administration 1
  • Timing: Administer once daily, preferably in the morning before meals for optimal acid suppression 2, 3

Dose Escalation for Refractory Cases

If standard dosing proves insufficient after 4-8 weeks of treatment:

  • Severe or refractory GERD: May require escalation up to 1.4-2.8 mg/kg/day in divided doses (approximately 32-63 mg/day for a 22.6 kg child) 1
  • Eosinophilic esophagitis: Initial treatment is 1 mg/kg twice daily (approximately 23 mg twice daily, up to maximum 40 mg twice daily) 1

Common Pitfalls to Avoid

  • Do not use adult dosing: Even though 20 mg is also a common adult dose, the indication here is weight-based pediatric dosing, not age-based adult dosing 1
  • Do not underdose: Children at 22.6 kg require the 20 mg dose, not the 10 mg dose used for lighter children 1
  • Monitor for side effects: Headaches, diarrhea, and nausea occur in approximately 14% of pediatric patients on prolonged therapy 1

Long-Term Monitoring

For treatment extending beyond 2.5 years, be aware that up to 50% of children may develop enterochromaffin cell hyperplasia, though this is generally reversible upon discontinuation. 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.